Cerus (CERS) Profit After Tax Growth (1y) (2011 - 2026)
Cerus (CERS) Profit After Tax Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -47.84% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 44.34% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 18.66% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 13.84% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -27.98% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 38.54% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 14.60% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 71.04% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 12.92% |
| 10 | Cerus | 562.58 Mn | 506.32 Mn | 29.53 Mn | 47.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.82% |
| Mar 31, 2026 | 78.75% |
| Dec 31, 2025 | 13.70% |
| Sep 30, 2025 | 99.32% |
| Jun 30, 2025 | 1.04% |
| Mar 31, 2025 | 20.36% |
| Dec 31, 2024 | -69.52% |
| Sep 30, 2024 | 59.63% |
| Jun 30, 2024 | 56.68% |
| Mar 31, 2024 | 38.05% |
| Dec 31, 2023 | 89.09% |
| Sep 30, 2023 | 14.32% |
| Jun 30, 2023 | -58.80% |
| Mar 31, 2023 | -27.33% |
| Dec 31, 2022 | -49.41% |
| Sep 30, 2022 | 31.80% |
| Jun 30, 2022 | 45.35% |
| Mar 31, 2022 | 29.63% |
| Dec 31, 2021 | 36.59% |
| Sep 30, 2021 | 12.04% |